Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 4 , ISSUE 1 ( January-June, 2015 ) > List of Articles


Current approaches to the assessment and treatment of acute severe asthma

Ruben D Restrepo, Andrew Tate, Donna D Gardner, Leonard D Wittnebel, Richard Wettstein, Felix Khusid

Keywords : Asthma, asthma disease management, asthma therapy, acute severe asthma, refractory asthma, status asthmaticus

Citation Information : Restrepo RD, Tate A, Gardner DD, Wittnebel LD, Wettstein R, Khusid F. Current approaches to the assessment and treatment of acute severe asthma. Indian J Respir Care 2015; 4 (1):521-541.

DOI: 10.5005/jp-journals-11010-04102

License: NA

Published Online: 02-12-2022

Copyright Statement:  NA


Despite the decline in overall asthma mortality, acute severe asthma continues to be a significant challenge to clinicians. Patients with acute severe asthma present unique clinical features that require early recognition and aggressive treatment. The aim of this review is to describe the most current evidence that supports diagnostic and therapeutic approaches in the management of patients with acute severe asthma in the clinical setting.

  1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma; executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-78.
  2. Beasley R. the Global Burden of Asthma Report, Global Initiative for Asthma (GINA). Available at 2004. Accessed August 22, 2013.
  3. Braman SS. The global burden of asthma. Chest 2006;130:4S-12S.
  4. McFadden ER Jr. Acute severe asthma. Am J Respir Crit Care Med 2003;168:740–59.
  5. National Heart, Lung, and Blood Institute (NHLBI). Managing Exacerbations of Asthma. NIH Publication No.: 07-4051. 2007. Available at: Accessed July 17, 2013.
  6. Fernandez Nievas IF, Anand KJS. Severe acute asthma exacerbation in children: A stepwise approach for escalating therapy in a pediatric intensive care unit. J Pediatr Pharmacol Ther 2013;18:88-104.
  7. Peters JI, Stupka JE, Singh H, Rossrucker J, Angel LF, et al. Status asthmaticus in the medical intensive care unit: A 30-year experience. Respir Med 2012;106:344-8.
  8. Romagnoli M, Caramori G, Braccioni F, Ravenna F, Barreiro E, Siafakas NM, et al and the ENFUMOSA Study Group. Near-fatal asthma phenotype in the ENFUMOSA Cohort. Clin Exp Allergy 2007;37:552–7.
  9. Picado C. Classification of severe asthma exacerbations: a proposal. Eur Respir J 1996;9:1775–8.
  10. Friedlander AL. Fatal and near-fatal asthma: phenotypes, precipitating factors, and management. The Respiratory Report 2007;3:22-33.
  11. Krishnan V, Diette GB, Rand CS, Bilderback AL, Merriman B, Hansel NN, et al. Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med 2006;174:633-8.
  12. Benatar SR. Fatal asthma. N Engl J Med 1986;314:423-9.
  13. Lavorini F, Levy ML, Corrigan C, Crompton G. The ADMIT series - issues in inhalation therapy. Training tools for inhalation devices. Prim Care Respir J 2010;19:335-41.
  14. Moore WC, Meyers DA, Wenzei SE, Teague WG, et al. Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010;181:315-22.
  15. Rodrigo GJ, Rodrigo C, Nannini LJ. Fatal or near-fatal asthma: clinical entity or incorrect management? Arch Bronconeumol 2004;40:24–33.
  16. Molfino NA, Nannini LJ, Martelli AN, Slutsky AS. Respiratory arrest in near-fatal asthma. N Engl J Med 1991;324:285-8.
  17. Roe PF. Sudden death in asthma. Brit J Dis Chest 1965;59:158-163.
  18. Corren J. Asthma Phenotypes and Endotypes: An Evolving Paradigm for Classification. Discov Med 2013;15:243-9.
  19. Sur S, Crotty TB, Kephart GM, Hyma BA, Colby TV, Reed CE, et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am J Respir Crit Care Med 1993;148:713-9.
  20. Lockey RF, Kiley JP, et-al. Asthma Phenotypes Task Force Goals and Objectives. National Heart, Lung, and Blood Institute. National Institute of Allergy and Infectious Diseases. American Academy of Allergy, Asthma & Immunology. American Thoracic Society. European Respiratory Society. Available at: Accessed August 14, 2013.
  21. Wasserfallen J-B, Schaller M-D, Feihl F, Perret CH. Sudden asphyxic asthma: a distinct entity? Am Rev Respir Dis 1990;142:108-1.
  22. Jones L, Goodacre S. Magnesium sulfate in the treatment of acute asthma: Evaluation of current practice in adult emergency departments. Emerg Med J 2009;26:783-5.
  23. Lugogo N, MacIntyre N. Life threatening asthma: Pathophysiology and management. Respir Care 2008; 53:726-39.
  24. Braman SS. The global burden of asthma. Chest 2006;130(1 Suppl):4S-12S.
  25. McFadden ER Jr. Fatal and near-fatal asthma. N Engl J Med 1991;324:409-11.
  26. Roe PF. Sudden death in asthma. Brit J Dis Chest 1965;59:158-63.
  27. Rodrigo C. Severe acute asthma: its management in mergency visits and intensive care. Med Intensiva 2006;30:460-70.
  28. Gelb AF, Schein A, Nussbaum E, Shinar CM, Aelony Y, Aharonian H, et al. Risk factors for near-fatal asthma. Chest 2004;126:1138–46.
  29. Alvarez GG, Schulzer M, Jung D, Fitzgerald JM. A systematic review of risk factors associated with near-fatal and fatal asthma. Can Respir J 2005;12:265-70.
  30. Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF, et al. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003;22:478–83.
  31. Serrano J, Plaza V, Sureda B, de Pablo J, Picado C, Bardagi S, et al. Alexithymia: a relevant psychological variable in near-fatal asthma. Eur Respir J 2006;28:296-302.
  32. Reck CL, Fiterman-Molinari D, Barreto SS, Et-al. Poor perception of dyspnea following methacholine challenge test in patients with asthma. J Bras Pneumol 2010;36:539-44.
  33. Magadle R, Berar-Yanay N, Weiner P. The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea. Chest 2002;121:329–33.
  34. Collins JE, Gill TK, Chittleborough CR, Martin AJ, Taylor AW, Winefield H. Mental, emotional, and social problems among school children with asthma. J Asthma 2008;45:489–93.
  35. Ritz T, Steptoe A, Dewilde S, Costa M. Emotions and stress increase respiratory resistance in asthma. Psychosom Med 2000;62:401–12.
  36. Álvarez Puebla MJ, García Río F. Physiology and physiopathology of the distal airways in asthma. Arch Bronconeumol 2011;47:10-6.
  37. Blanch L, Bernabé F, Lucangelo U. Measurement of air trapping, intrinsic positive end-expiratory pressure, and dynamic hyperinflation in mechanically ventilated patients. Respir Care 2005;50:1101-23.
  38. Rodriguez-Roisin R: Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities. Eur Respir J 1997;10:1359-71.
  39. Raimondi GA, Gonzalez S, Zaltsman J, Adrogué HJ. Acid-Base Patterns in Acute Severe Asthma. J Asthma 2013;50:1062-8.
  40. US Department of Health and Human Services. National Asthma Education and Prevention Program. Expert Panel report 3: guidelines for the diagnosis and management of asthma. Summary report 2007. NIH Publication no.: 08-5846 [online]. Available at: http://www.nhlbi. Accessed August 26, 2013.
  41. Lemarchand P, Labrune S, Herer B, Huchon GJ. Cardiorespiratory arrest following peak expiratory flow measurement during attack of asthma. Chest 1991;100:1168-9.
  42. Hetzel MR, Clark TJH, Branthwaite MA. Asthma: analysis of sudden deaths and ventilatory arrests in hospital. Br Med J 1977;1:808-11.
  43. Morjaria JB, Polosa R. Recommendations for optimal management of severe refractory asthma. J Asthma Allergy 2010;3:43-56.
  44. Meert KL, Clark J, Sarnaik AP. Metabolic acidosis as an underlying mechanism of respiratory distress in children with severe acute asthma. Pediatr Crit Care Med 2007;8:519-23.
  45. Barnes PJ. Theophylline. Am J Respir Crit Care Med 2013;188:901-996.
  46. White CS, Cole RP, Lubetsky HW, Austin JH. Acute asthma: admission chest radiography in hospitalized adult patients. Chest 1991;100:14-6.
  47. Khalid MS, Ahmad N, Moin S, El-Faedy O, Gaffney P. Spontaneous pneumomediastinum: a rare complication of acute asthma. Ir J Med Sci 2008;177:393-6.
  48. Faruqi S, Varma R, Greenstone MA, Kastelik JA. Spontaneous pneumomediastinum: a rare complication of bronchial asthma. J Asthma 2009;46:969-71.
  49. Spottswood SE, Allison KZ, Lopatina OA, Sethi NN, Narla LD, et al. The clinical significance of lung hypoexpansion in acute childhood asthma. Pediatr Radiol 2004;34:322-5.
  50. Lee YM, Park JS, Hwang JH, Park SW, Uh ST, Kim YH, et al. High-resolution CT findings in patients with near-fatal asthma. Comparison of patients with mild-to-severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment. Chest 2004;126:1840–8.
  51. Hyung KY, Kyung LY, Yoo JH. Changes in CT scan-estimated airway dimensions during an acute exacerbation of asthma. Intern Med 2013;52:679-83.
  52. Shah KH, Slovis BH, Runde D, et al. Radiation exposure among patient with the highest CT scan utilization in the emergency department. Emerg Radiol 2013;20:485-91.
  53. Fadden ER, Elsanadi N, Dixon L, Takacs M, Deal EC, Boyd KK, et al. Protocol therapy for acute asthma: therapeutics benefits and cost savings. Am J Med 1995; 99: 651-61.
  54. Kelly AM, Kerr D, Powell C. Is severity assessment after one hour of treatment better for predicting the need for admission in acute asthma? Respir Med 2004; 98: 777–81.
  55. Kelly AM, Powell C, Kerr D. Patients with a longer duration of symptoms of acute asthma are more likely to require admission to hospital. Emerg Med 2002; 14: 142–5.
  56. Papiris SA, Manali ED, Kolilekas L, Triantafillidou C, Tsangaris I. Acute severe asthma: New approaches to assessment and treatment. Drugs 2009; 69: 2363-91.
  57. Boychuk RB, Yamamoto LG, DeMesa CJ, Kiyabu KM. Correlation of initial emergency department pulse oximetry values in asthma severity classes (steps) with the risk of hospitalization. Am J Emerg Med 2006; 24:48–52.
  58. Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev 2000;(4):CD000060.
  59. Pollack CV Jr, Pollack ES, Baren JM, et al. Multicenter Airway Research Collaboration Investigators. A prospective multicenter study of patient factors associated with hospital admission from the emergency department among children with acute asthma. Arch Pediatr Adolesc Med 2002; 156: 934–40.
  60. Weber EJ, Silverman RA, Callaham ML, Pollack CV Jr, Woodruff PG, Clark S, Camargo CA Jr. A prospective multicenter study of factors associated with hospital admission among adult with acute asthma. Am J Med 2002; 113: 371–8.
  61. Nelson KA, Zorc JJ. Management of acute asthma. Adolesc Med State Art Rev 2010; 21:21-33.
  62. O'Connell MB, Iber C. Continuous intravenous terbutaline infusions for adult patients with status asthmaticus. Ann Allergy 1990; 64: 213-8.
  63. Kelly A, Kennedy A, John BM, Duane B, Lemanowicz J, Little J. A comparison of heart rate changes associated with levalbuterol and racemic albuterol and in pediatric cardiology patients. Ann Pharmacother 2013; 47:644-50.
  64. Khorfan FM, Smith P. Watt S, Barber KR. Effects of nebulized bronchodilator therapy on heart rate and arrhythmias in critically ill adult patients. Chest 2011; 140: 1466-72.
  65. Andrews T, McGinbee E, Mittal MK, Tyler L, Chew A, Zhang X, et al. High-Dose Continuous Nebulized Levalbuterol for Pediatric Status Asthmaticus: A Randomized Trial. J Pediatr 2009; 155: 205-10.
  66. Newhouse M. Emergency department management of life-threatening asthma: are nebulizers obsolete? Chest 1993; 103: 661-3.
  67. Cates CC, Bara A, Crilly JA, Rowe BH. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2003;(3):CD000052.
  68. Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev 2003b; (4):CD001115.
  69. Lin RY, Sauter D, Newman T, Sirleaf J, Walters J, Tavakol M. Continuous versus intermittent albuterol nebulization in the treatment of acute asthma. Ann Emerg Med 1993; 22:1847-53.
  70. Rudnitsky GS, Eberlein RS, Schoffstall JM, Mazur JE, Spivey WH. Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department. Ann Emerg Med 1993; 22: 1842-6.
  71. Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993; 21: 1479-86.
  72. Maury E, Ioos V, Lepecq B, Guidet B, Offenstadt G. A paradoxical effect of bronchodilators. Chest 1997; 111:1766-7.
  73. Liem EB, Mnookin SC, Mahla ME. Albuterolinduced lactic acidosis. Anesthesiology 2003; 99: 505-6.
  74. Kovacevic A, Schwahn B, Schuster A. Hyperlactic acidosis as metabolic side-effect of albuterol and theophylline in acute severe asthma. Klin Padiatr 2010; 222: 271-2.
  75. Claret PG, Bobbia X, Boutin C, Rougier M, de la Coussaye JE. Lactic acidosis as a complication of â-adrenergic aerosols. Am J Emerg Med 2012;30: 1319.e5-6.
  76. Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005; 60: 740–6.
  77. Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev 2000;(4):CD000060.
  78. Craven D, Kercsmar CM, Myers TR, O'Riordan MA, Golonka G, Moore S. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. J Pediatr 2001; 138: 51–8.
  79. Rodrigo GJ, Rodrigo C. First line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratoprium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 2000; 161: 862-1868.
  80. Sharma A, Madan A. Subcutaneous epinephrine vs nebulized salbutamol in asthma. Indian J Pediatr 2001; 68: 1127-30.
  81. Cydulka R, Davison R, Grammer L, Parker M, Mathews J IV. The use of epinephrine in the treatment of older adult asthmatics. Ann Emerg Med 1988; 17: 322-6.
  82. Putland M, Kerr D, Kelly AM. Adverse events associated with the use of intravenous epinephrine in emergency department patients presenting with severe asthma. Ann Emerg Med 2006; 47:559-63.
  83. Sellers WF. Inhaled and intravenous treatment in acute severe and life-threatening asthma. Br J Anaesth 2013; 110: 183-90.
  84. Bogie AL, Towne D, Luckett PM, Abramo TJ, Wiebe RA. Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus. Pediatr Emerg Care 2007; 23: 355-61.
  85. Travers AH, Milan SJ, Jones AP, Camargo CA Jr, Rowe BH. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma. Cochrane Database Syst Rev 2012; 12:CD010179.
  86. Pascual RM, Bleecker ER. Pharmacogenetics of asthma. Curr Opin Pharmacol 2010; 10: 226-35.
  87. Gibson PG, Saltos N, Fakes K. Acute antiinflammatory effects of inhaled budesonide in asthma. Am J Respir Crit Care Med 2001; 163: 32-6.
  88. Lahn M, Bijur P, Gallagher EJ. Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest 2004; 126: 362–8.
  89. Chian CF, Tsai CL, Wu CP, Chiang CH, Su WL, Chen CW, Perng WC. Five-day course of budesonide inhalation suspension is as effective as oral prednisolone in the treatment of mild to severe acute asthma exacerbations in adults. Pulm Pharmacol Ther 2011; 24: 256-60.
  90. Sin DD, Tu JV. Inhaled corticosteroid therapy reduces the risk of rehospitalization and allcause mortality in elderly asthmatics. Eur Respir J 2001; 17: 380-5.
  91. Ediger D, Coskun F, Uzaslan E, Yuksel E, Karadag M, Ege E. Clinical effectiveness of nebulized budenoside in the treatment of acute severe asthma attacks. Tuberkulozve Toraks Dergisi 2006; 54: 128-36.
  92. Harrison TW, Oborne J, Newton S, Tattersfield AE. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet 2004; 363: 271–5.
  93. Volovitz B, Bilavsky E, Nussinovitch M. Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. J Asthma 2008; 45: 561-7.
  94. Rodrigo GJ. Inhaled corticosteroids as rescue medication in acute severe asthma. Expert Rev Clin Immunol 2008; 4: 723-9.
  95. Edmonds ML, Milan SJ, Camargo CA Jr, Pollack CV Jr, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2012; 12:CD002308.
  96. FitzGerald JM, Becker A, Sears MR, Mink S, Chung K, Lee J. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax 2004; 59: 550–6.
  97. Melani AS. Nebulized corticosteroids in asthma and COPD. An Italian appraisal. Respir Care 212; 57: 1161-74.
  98. Rodrigo GJ. Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. Am J Respir Crit Care Med 2005; 171: 1231–6.
  99. Kravitz J, Dominici P, Ufberg J, Fisher J, Giraldo P. Two days of dexamethasone versus 5 days of prednisone in the treatment of acute asthma: a randomized controlled trial. Ann Emerg Med 2011; 58: 200-4.
  100. Shefrin A, Goldman R. Use of dexamethasone and prednisone in acute asthma exacerbations in pediatric patients. Canadian Family Physician 2009; 55: 704-6.
  101. Self TH, Redmond AM, Ngyen WT. Reassessment of theophylline use for severe asthma exacerbation: is it justified in critically ill patients? J Asthma 2002; 39:677-86.
  102. Rodrigo C, Rodrigo G. Treatment of acute asthma. Lack of therapeutic benefit and increase of toxicity from aminophylline given in addition to high doses of salbutamol delivered by metered-dose inhaler with a spacer. Chest 1994; 106: 1071-6.
  103. Mitra A, Bassler D, Goodman K, Lasserson TJ, Ducharme FM. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Database Syst Rev 2005;(2):CD001276.
  104. Silverman R, Nowak R, Korenblat P, et al. Zafirlukast treatment for acute asthma: evaluation in a randomized, double blind, multicenter trial. Chest 2004; 126: 1480-9.
  105. Dockhorn RJ, Baumgartner RA, Leff JA, Noonan M, Vandormael K, Stricker W, Weinland DE, Reiss TF. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 2000; 55: 260–5.
  106. Camargo CA, Smithline HA, Malice MP, Green SA, Reiss TF. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 2003; 167: 528–33.
  107. Silverman RA, Miller CJ, Chen Y. Zafirlukast reduces relapse and treatment failure after an acute asthma episode. Chest 2004; 125: 1081-102.
  108. Song WJ, Chang YS. Magnesium sulfate for acute asthma in adults: a systematic literature review. Asia Pac Allergy 2012; 2: 76-85.
  109. Silverman RA, Osborn H, Runge J et al. Acute Asthma/Magnesium Study Group. IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial. Chest 2002; 122: 489–97.
  110. Jones L, Goodacre S. Magnesium sulfate in the treatment of acute asthma: evaluation of current practice in adult emergency departments. Emerg Med J 2009; 26: 783-5.
  111. Rowe BH, Bretzlaff J, Bourdon C, Bota G, Blitz S, Camargo CA. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database of Systematic Reviews. 2000; 1:CD001490.
  112. Cheuk DK, Chau TC, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child 2005; 90: 74–7.
  113. Scarfone RJ, Loiselle JM, Joffe MD, et al. A randomized trial of magnesium in the emergency department treatment of children with asthma. Ann Emerg Med 2000; 36: 572–8.
  114. Porter RS, Nester, Braitman LE, Geary U, Dalsey WC. Intravenous magnesium is ineffective in adult asthma, a randomized trial. Eur J Emerg Med 2001; 8: 9–15.
  115. Global Initiative for Asthma. Global strategy for asthma management and prevention, updated December 2012 [online]. Available at: Accessed August 13, 2013.
  116. Blitz M, Blitz S, Hughes R, et al. Aerosolized magnesium sulfate for acute asthma: a systematic review. Chest 2005;128:337–44.
  117. Kress JP, Noth I, Gehlbach BK, et al. The utility of albuterol nebulized with heliox during acute asthma exacerbations. Am J Respir Crit Care Med 2002; 165: 1317-21.
  118. Rose, JS, Panacek, EA, Miller, P Prospective randomized trial of heliox-driven continuous nebulizers in the treatment of asthma in the emergency department. J Emerg Med 2002;22:133-7.
  119. Bag R, Bandi V, Fromm RE Jr, Guntupalli KK. The effect of heliox-driven bronchodilator aerosol therapy on pulmonary function tests in patients with asthma. J Asthma 2002; 39: 659–65.
  120. Kim IK, Phrampus E, Venkataraman S, et al. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics 2005; 116: 1127-33.
  121. Lee DL, Hsu CW, Lee H, Chang HW, Huang YC. Beneficial effects of albuterol therapy driven by heliox versus by oxygen in severe asthma exacerbation. Acad Emerg Med 2005; 12: 820–7.
  122. Rivera ML, Kim TY, Stewart GM, Minasyan L, Brown L. Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: a blinded, randomized controlled trial. Am J Emerg Med 2006;24:38–42.
  123. Gluck, EH, Onorato, DJ, Castriotta, R. Heliumoxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis. Chest 1990; 98:693-8.
  124. Henderson SO, Acharya P, Kilaghbian T. Use of heliox driven nebuliser therapy in the treatment of acute asthma. Ann Emerg Med 1999;33:141–6.
  125. Gupta VK, Cheifetz IM. Heliox administration in the pediatric intensive care unit: an evidencebased review. Pediatr Crit Care Med 2005;6:204–11.
  126. Soroksky A, Stav D, Shpirer I. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest 2003;123:1018-25.
  127. Meduri GU, Cook TR, Turner RE, Cohen M, Leeper KV. Noninva- sive positive pressure ventilation in status asthmaticus. Chest 1996;110:767-74.
  128. Gupta D, Nath A, Agarwal R, Behera D. A prospective randomized controlled trial on the efficacy of noninvasive ventilation in severe acute asthma. Respir Care 2010;55:536-43.
  129. Fernandez MM, Villagra A, Blanch L, Fernandez R. Non-invasive mechanical ventilation in status asthmaticus. Intensive Care Med 2001;27:486-92.
  130. Beers SL, Abramo TJ, Bracken A, Wiebe RA. Bilevel positive airway pressure in the treatment of status asthmaticus in pediatrics. Am J Emerg Med 2007;25:6-9.
  131. Lim WJ, Mohammed AR, Carson KV, Mysore S, Labiszewski NA, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrance Database Syst Rev 2012;12:CD004360.
  132. Tuxen DV, Andersen MB, Scheinkestel CD. Mechanical ventilation for severe asthma. In: Hall JB, Corbridge TC, Rodrigo C, Rodrigo GV, editors. Acute asthma: assessment and management. New York McGraw Hill 2000:229–8.
  133. Allen JY, Macias CG. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med 2005;46:43–50.
  134. Takasaki Y, Kido T, Semba K. Dexmedetomidine facilitates induction of noninvasive positive pressure ventilation for acute respiratory failure in patients with severe asthma. J Anesth 2009;23:147-50.
  135. Adnet F, Dhissi G, Borron SW, Galinski M, Rayeh F, Cupa M, et al. Complication profiles of adult asthmatics requiring paralysis during mechanical ventilation. Intensive Care Med 2001;27:1729-36.
  136. Kesler SM, Sprenkle MD, David WS, Leatherman JW. Severe weakness complicating status asthmaticus despite minimal duration of neuromuscular paralysis. Intensive Care Med 2009;35:157-60.
  137. Louie S, Morrissey BM, Kenyon NJ, Albertson TE, Avdalovic M. The critically ill asthmaticfrom ICU to discharge. Clin Rev Allergy Immunol 2012;43:30-44.
  138. Georgopoulos D, Kondili E, Prinianakis G. How to set the ventilator in asthma. Monaldi Arch Chest Dis 2000;55:74-83.
  139. Tuxen DV. Detrimental effects of positive end-expiratory pressure during controlled mechanical ventilation of patients with severe airflow obstruction. Am Rev Respir Dis 1989;140:5-9.
  140. Carroll CL, Zucker AR. Barotrauma not related to type of positive pressure ventilation during severe asthma exacerbations in children. J Asthma 2008;45(5):421-4.
  141. Winters M. Ventilator Management of the Intubated Patient with Asthma. J Emerg Med 2011;40:419-27.
  142. Guntupalli K, Bandi V. Ventilation of patients with severe obstructive lung disease. In: Dellinger R, editor. Current topics in intensive care: asthma. London: Saunders; 1996.
  143. Leatherman JW. Mechanical Ventilation for Severe Asthma. Respiratory Care 2007; 52:1460-2.
  144. Medoff BD. Invasive and noninvasive ventilation in patients with asthma. Respir Care 2008;53:740-8.
  145. Leatherman JW, McArthur C, Shapiro RS. Effect of prolongation of expiratory time on dynamic hyperinflation in mechanically ventilated patients with severe asthma. Crit Care Med 2004;32:1542-5.
  146. Stather DR, Stewart TE. Clinical review: Mechanical ventilation in severe asthma. Critical Care 2005;9:581-7.
  147. Pepe PE, Marini JJ. Occult positive endexpiratory pressure in mechanically ventilated patients with airflow obstruction: the auto- PEEP effect. Am Rev Respir Dis 1982;126:166–70.
  148. Tuxen DV, Lane S. The effects of ventilatory pattern on hyperinflation, airway pressures, and circulation in mechanical ventilation of patients with severe air-flow obstruction. Am Rev Respir Dis 1987;136:872–9.
  149. Kondili E, Prinianakis G, Georgopoulos D. Patient-ventilator inter- action. Br J Anaesth 2003;91:106–19.
  150. Sassoon CS, Foster GT. Patient-ventilator asynchrony. Curr Opin Crit Care 2001;7:28–33.
  151. Blanch L, Lucangelo U, Fernandez R, Baigorri F, De Monte A, Saura P, et al. Efecto de la PEEP sobre la mecanica pulmonar y el capnograma espiratorio en pacientes con enfermedad pulmonar obstructiva cronica ventilados mecanicamente. Med Intensiva 1995;19:304–12.
  152. Oddo M, Feihl F, Schaller MD, Perret C. Management of mechanical ventilation in acute severe asthma: practical aspects. Intensive Care Med 2006;32:501-10.
  153. Levy BD, Kitch B, Fanta CH. Medical and ventilatory management of status asthmaticus. Intensive Care Med 1998;24:105-17.
  154. Sydow M, Golisch W, Buscher H, Zinserling J, Crozier TA, Burchardi H. Effect of low-level PEEP on inspiratory work of breathing in intubated patients, both with healthy lungs and with COPD. Intensive Care Med 1995;21:887-95.
  155. McFadden ER Jr, Ingram RH Jr, Haynes RL, Wellman JJ. Predominant site of flow limitation and mechanisms of postexertional asthma. J Appl Physiol 1977;42:746-52.
  156. Tuxen DV. Detrimental effects of positive end-expiratory pressure during controlled mechanical ventilation of patients with severe air- flow obstruction. Am Rev Respir Dis 1989;140:5–9.
  157. Ranieri VM, Grasso S, Fiore T, Giuliani R. Autopositive end-ex- piratory pressure and dynamic hyperinflation. Clin Chest Med 1996;17:379-94.
  158. Caramez MP, Borges JB, Tucci MR, Okamoto VN, Carvalho CR, Kacmarek RM, et al. Paradoxical responses to positive endexpiratory pressure in patients with airway obstruction during controlled ventilation. Crit Care Med 2005;33:1519-28.
  159. Chonghaile MN, Higgins B, Laffey JG. Permissive hypercapnia: role in protective lung ventilatory strategies. Curr Opin Crit Care 2005;11:56-62.
  160. Menitove SM, Goldring RM. Combined ventilator and bicarbonate strategy in the management of status asthmaticus. Am J Med 1983;74:898–901.
  161. Mutlu GM, Factor P, Schwartz DE, Sznajder JI. Severe status asthmaticus: Management with permissive hypercapnia and inhalation anesthesia. Crit Care Med 2002;30:477-80.
  162. Mutch WA, Buchman TG, Girling LG, Walker EK, McManus BM, Graham MR. Biologically variable ventilation improves gas exchange and respiratory mechanics in a model of severe bronchospasm. Crit Care Med 2007;35:1749-55.
  163. Kowalski S, McMullen MC, Girling LG, McCarthy BG. Biologically variable ventilation in patients with acute lung injury: a pilot study. Can J Anaesth 2013;60:502-3.
  164. Vargas F, Bui HN, Boyer A, et al. Intrapulmonary percussive ventilation in acute exacerbations of COPD patients with mild respiratory acidosis: a randomized controlled trial. Crit Care 2005; 9:R382-R389.
  165. Chatburn RL. High-frequency assisted airway clearance. Respir Care 2007; 52:1224-35.
  166. Soland V, Brock G, King M. Effect of airway wall flexibility on clearance by simulated cough. J Appl Physiol 1987; 63:707-12.
  167. Ides K, Vos W, De Backer L, Vissers D, et al. Acute effects of intrapulmonary percussive ventilation in COPD patients assessed by using conventional outcome parameters and a novel computational fluid dynamics technique. Int J Chron Obstruct Pulmon Dis 2012;7:667-71.
  168. Restrepo RD, Pettignano R, DeMeuse P. Halothane, an effective infrequently used drug, in the treatment of pediatric status asthmaticus: a case report. J Asthma 2005;42:649-651.
  169. Turner DA, Heitz D, Cooper MK, Smith PB, Arnold JH, Bateman ST. Isoflurane for lifethreatening bronchospasm: a 15-year singlecenter experience. Respir Care 2012;57:1857-64.
  170. Rooke GA, Choi JH, Bishop MJ. The effect of isoflurane, halothane, sevoflurane and thiopental/nitrous oxide on respiratory system resistance after tracheal intubation. Anesthesiology 1997;86:1294-9.
  171. Burburan SM, Xisto DG, Rocco PR. Anaesthetic management in asthma. Minerva Anestesiol 2007;73:357-65.
  172. Walsh BK, Green M. Inhaled anesthetic for lifethreatening bronchospasm: is it ready for prime time? Respir Care 2012;57:1982-3.
  173. Woods BD, Sladen RN. Perioperative considerations for the patient with asthma and bronchospasm. Br J Anaesth 2009;103:i57-i65.
  174. Groeben H, Peters J. Lidocaine exerts its effect on induced bronchospasm by mitigating reflexes, rather than be attenuation of smooth muscle contraction. Acta Anaesthesiol Scand 2007:51:359-64.
  175. Jooste E, Klafter F, Hirshman CA, Emala CW. A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism. Anesthesiology 2003:98:906-11.
  176. Bishop MJ, O'Donnell JT, Pharm D, Salemi JR. Mivacurium and bronchospasm. Anesth Analg 2003:97:484-5.
  177. Hebbar KB, Petrillo-Albarano T, Coto-Puckett W, Heard M, Rycus PT, Fortenberry JD. Experience with use of extracorporeal life support for severe refractory status asthmaticus in children. Crit Care 2009;13:R29.
  178. American Lung Association Epidemiology and Statistics Unit, Research and Program Services. Trends in asthma morbidity and mortality. New York: American Lung Association; 2012. Available at: report.pdf. Accessed August 26, 2013.
  179. Camargo CA Jr, Emond SD, Boulet L, Gibson PG, Kolbe J, Wagner CW, Brenner BE. Emergency Department-Asthma Discharge Plan. Developed at “Asthma Education in the Adult Emergency Department: A Multidisciplinary Consensus Conference,” New York Academy of Medicine, New York, NY; 2001 April 1–5. Boston, MA: Massachusetts General Hospital, 2001. 2 pp.
  180. Sin DD, Bell NR, Svenson LW, Man SF. The impact of follow-up physician visits on emergency readmissions for patients with asthma and chronic obstructive pulmonary disease: a population-based study. Am J Med 2002;112:120–5.
  181. Baren JM, Boudreaux ED, Brenner BE, Cydulka RK, Rowe BH, Clark S, Camargo CA Jr. Randomized controlled trial of emergency department interventions to improve primary care follow-up for patients with acute asthma. Chest 2006;129:257–65.
  182. Ho J, Bender BG, Gavin LA, O'Connor SL, Wamboldt MZ, Wamboldt FS. Relations among asthma knowledge, treatment adherence, and outcome. J Allergy Clin Immunol 2003;111:498–502.
  183. Silverman RA, Boudreaux ED, Woodruff PG, Clark S, Camargo CA Jr. Cigarette smoking among asthmatic adults presenting to 64 emergency departments. Chest 2003;123:1472–9.
  184. Smith SR, Jaffe DM, Fisher EB Jr, Trinkaus KM, Highstein G, Strunk RC. Improving follow-up for children with asthma after an acute Emergency Department visit. J Pediatr 2004;145:772–7.
  185. Price D, Bosnic-Anticevich S, Briggs A, Chrystyn H, Rand C, Scheuch G, et-al. Inhaler competence in asthma: Common errors, barriers to use and recommended solutions. Respiratory Medicine 2013;107:37-46.
  186. Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, et al. Inhaler mishandling remains common in in real life and is associated with reduced disease control. Respiratory Medicine 2011;105:930-8.
  187. Grimaldi-Bensouda L, Zureik M, Aubier M, Humbert M, Levy J, Benichou J, et al. Pharmacoepidemiology of Asthma and Xolair (PAX) Study Group. Does omalizumab make a difference to the real-life treatment of asthma exacerbations? Results from a large cohort of patients with severe uncontrolled asthma. Chest 2013;143:398-405.
  188. Siergiejko Z, Œwiebocka E, Smith N, Peckitt C, Leo J, Peachey G, Maykut R. Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients. Curr Med Res Opin 2011;27:2223-8.
  189. Wechsler ME, Laviolette M, Rubin AS et al. Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol 2013; 1
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.